Type |
Details |
Score |
Publication |
First Author: |
Walker W |
Year: |
2005 |
Journal: |
J Cell Biol |
Title: |
Mnt-Max to Myc-Max complex switching regulates cell cycle entry. |
Volume: |
169 |
Issue: |
3 |
Pages: |
405-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang Y |
Year: |
2021 |
Journal: |
Cancer Discov |
Title: |
Tumor Microenvironment-Derived R-spondins Enhance Anti-Tumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Weihua X |
Year: |
1997 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc. |
Volume: |
94 |
Issue: |
14 |
Pages: |
7227-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fiancette R |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. |
Volume: |
187 |
Issue: |
11 |
Pages: |
5772-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blyth K |
Year: |
1995 |
Journal: |
Oncogene |
Title: |
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. |
Volume: |
10 |
Issue: |
9 |
Pages: |
1717-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Santoni-Rugiu E |
Year: |
1999 |
Journal: |
Am J Pathol |
Title: |
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. |
Volume: |
154 |
Issue: |
6 |
Pages: |
1693-700 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sandgren EP |
Year: |
1991 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Pancreatic tumor pathogenesis reflects the causative genetic lesion. |
Volume: |
88 |
Issue: |
1 |
Pages: |
93-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vallespinós M |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
B Lymphocyte commitment program is driven by the proto-oncogene c-Myc. |
Volume: |
186 |
Issue: |
12 |
Pages: |
6726-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Laurenti E |
Year: |
2008 |
Journal: |
Cell Stem Cell |
Title: |
Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. |
Volume: |
3 |
Issue: |
6 |
Pages: |
611-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kanatsu-Shinohara M |
Year: |
2016 |
Journal: |
Genes Dev |
Title: |
Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal. |
Volume: |
30 |
Issue: |
23 |
Pages: |
2637-2648 |
|
•
•
•
•
•
|
Publication |
First Author: |
Soucek L |
Year: |
2007 |
Journal: |
Nat Med |
Title: |
Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. |
Volume: |
13 |
Issue: |
10 |
Pages: |
1211-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee H |
Year: |
2019 |
Journal: |
Nat Cell Biol |
Title: |
Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation. |
Volume: |
21 |
Issue: |
6 |
Pages: |
700-709 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saravia J |
Year: |
2020 |
Journal: |
Sci Adv |
Title: |
Homeostasis and transitional activation of regulatory T cells require c-Myc. |
Volume: |
6 |
Issue: |
1 |
Pages: |
eaaw6443 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cao Y |
Year: |
2015 |
Journal: |
EMBO J |
Title: |
miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency. |
Volume: |
34 |
Issue: |
5 |
Pages: |
609-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mucenski ML |
Year: |
1987 |
Journal: |
Oncogene Res |
Title: |
Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains. |
Volume: |
2 |
Issue: |
1 |
Pages: |
33-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sanders JA |
Year: |
2012 |
Journal: |
BMC Physiol |
Title: |
Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion. |
Volume: |
12 |
|
Pages: |
1 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bettess MD |
Year: |
2005 |
Journal: |
Mol Cell Biol |
Title: |
c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. |
Volume: |
25 |
Issue: |
17 |
Pages: |
7868-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang H |
Year: |
2016 |
Journal: |
J Biol Chem |
Title: |
Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma. |
Volume: |
291 |
Issue: |
51 |
Pages: |
26241-26251 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li F |
Year: |
2006 |
Journal: |
Cancer Res |
Title: |
Conditional deletion of c-myc does not impair liver regeneration. |
Volume: |
66 |
Issue: |
11 |
Pages: |
5608-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Edmunds LR |
Year: |
2016 |
Journal: |
Oncotarget |
Title: |
Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes. |
Volume: |
7 |
Issue: |
21 |
Pages: |
30379-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qi Y |
Year: |
2022 |
Journal: |
FASEB J |
Title: |
Endothelial c-Myc knockout enhances diet-induced liver inflammation and fibrosis. |
Volume: |
36 |
Issue: |
1 |
Pages: |
e22077 |
|
•
•
•
•
•
|
Publication |
First Author: |
Arnold I |
Year: |
2001 |
Journal: |
Curr Biol |
Title: |
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. |
Volume: |
11 |
Issue: |
8 |
Pages: |
558-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee HG |
Year: |
2009 |
Journal: |
PLoS One |
Title: |
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. |
Volume: |
4 |
Issue: |
9 |
Pages: |
e7172 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dolezal JM |
Year: |
2017 |
Journal: |
J Biol Chem |
Title: |
Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma. |
Volume: |
292 |
Issue: |
24 |
Pages: |
10068-10086 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anderton B |
Year: |
2017 |
Journal: |
EMBO Rep |
Title: |
MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer. |
Volume: |
18 |
Issue: |
4 |
Pages: |
569-585 |
|
•
•
•
•
•
|
Publication |
First Author: |
Woods SL |
Year: |
2011 |
Journal: |
Transgenic Res |
Title: |
A new transgenic mouse line for tetracycline inducible transgene expression in mature melanocytes and the melanocyte stem cells using the Dopachrome tautomerase promoter. |
Volume: |
20 |
Issue: |
2 |
Pages: |
421-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takizawa M |
Year: |
2010 |
Journal: |
Oncogene |
Title: |
Genetic reporter system for oncogenic Igh-Myc translocations in mice. |
Volume: |
29 |
Issue: |
28 |
Pages: |
4113-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu L |
Year: |
2020 |
Journal: |
FASEB J |
Title: |
miR-144/451 inhibits c-Myc to promote erythroid differentiation. |
Volume: |
34 |
Issue: |
10 |
Pages: |
13194-13210 |
|
•
•
•
•
•
|
Publication |
First Author: |
Trudel M |
Year: |
1998 |
Journal: |
Am J Pathol |
Title: |
Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. |
Volume: |
152 |
Issue: |
1 |
Pages: |
219-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Prendergast GC |
Year: |
1989 |
Journal: |
Mol Cell Biol |
Title: |
Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. |
Volume: |
9 |
Issue: |
1 |
Pages: |
124-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hann SR |
Year: |
1994 |
Journal: |
Genes Dev |
Title: |
The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. |
Volume: |
8 |
Issue: |
20 |
Pages: |
2441-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Müller JR |
Year: |
1997 |
Journal: |
Genes Chromosomes Cancer |
Title: |
Immunoglobulin/Myc recombinations in murine Peyer's patch follicles. |
Volume: |
20 |
Issue: |
1 |
Pages: |
1-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Felix K |
Year: |
2004 |
Journal: |
Cancer Res |
Title: |
Moderate hypermutability of a transgenic lacZ reporter gene in Myc-dependent inflammation-induced plasma cell tumors in mice. |
Volume: |
64 |
Issue: |
2 |
Pages: |
530-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rockwood LD |
Year: |
2002 |
Journal: |
Oncogene |
Title: |
Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations. |
Volume: |
21 |
Issue: |
47 |
Pages: |
7235-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luo H |
Year: |
2005 |
Journal: |
Blood |
Title: |
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. |
Volume: |
106 |
Issue: |
7 |
Pages: |
2452-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Murn J |
Year: |
2009 |
Journal: |
BMC Genomics |
Title: |
A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering. |
Volume: |
10 |
|
Pages: |
323 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang B |
Year: |
2014 |
Journal: |
Hepatology |
Title: |
Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. |
Volume: |
59 |
Issue: |
2 |
Pages: |
555-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamamoto T |
Year: |
2023 |
Journal: |
Sci Rep |
Title: |
MYC-MAX heterodimerization is essential for the induction of major zygotic genome activation and subsequent preimplantation development. |
Volume: |
13 |
Issue: |
1 |
Pages: |
16011 |
|
•
•
•
•
•
|
Publication |
First Author: |
Griesmann H |
Year: |
2009 |
Journal: |
Int J Cancer |
Title: |
p53 and p73 in suppression of Myc-driven lymphomagenesis. |
Volume: |
124 |
Issue: |
2 |
Pages: |
502-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Murakami H |
Year: |
1993 |
Journal: |
Cancer Res |
Title: |
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. |
Volume: |
53 |
Issue: |
8 |
Pages: |
1719-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Garbarini N |
Year: |
2008 |
Journal: |
Cell Physiol Biochem |
Title: |
The RCC1 domain of protein associated with Myc (PAM) interacts with and regulates KCC2. |
Volume: |
22 |
Issue: |
1-4 |
Pages: |
31-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Béguelin W |
Year: |
2020 |
Journal: |
Cancer Cell |
Title: |
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response. |
Volume: |
37 |
Issue: |
5 |
Pages: |
655-673.e11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mlynarczyk C |
Year: |
2023 |
Journal: |
Science |
Title: |
BTG1 mutation yields supercompetitive B cells primed for malignant transformation. |
Volume: |
379 |
Issue: |
6629 |
Pages: |
eabj7412 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bae S |
Year: |
2021 |
Journal: |
Cell Rep |
Title: |
MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages. |
Volume: |
35 |
Issue: |
11 |
Pages: |
109264 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hatton BA |
Year: |
2006 |
Journal: |
Cancer Res |
Title: |
N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. |
Volume: |
66 |
Issue: |
17 |
Pages: |
8655-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anderson DA |
Year: |
2022 |
Journal: |
J Exp Med |
Title: |
Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8. |
Volume: |
219 |
Issue: |
2 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Cabezas-Wallscheid N |
Year: |
2017 |
Journal: |
Cell |
Title: |
Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy. |
Volume: |
169 |
Issue: |
5 |
Pages: |
807-823.e19 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nieminen AI |
Year: |
2013 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis. |
Volume: |
110 |
Issue: |
20 |
Pages: |
E1839-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Valverde-Lopez JA |
Year: |
2024 |
Journal: |
PLoS Genet |
Title: |
P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition. |
Volume: |
20 |
Issue: |
3 |
Pages: |
e1011193 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jakobs PM |
Year: |
1999 |
Journal: |
Mamm Genome |
Title: |
Embryonic stem cells can be used to construct hybrid cell lines containing a single, selectable murine chromosome. |
Volume: |
10 |
Issue: |
4 |
Pages: |
381-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vo BT |
Year: |
2017 |
Journal: |
Cell Rep |
Title: |
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma. |
Volume: |
18 |
Issue: |
12 |
Pages: |
2907-2917 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2016 |
Journal: |
Oncotarget |
Title: |
BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia. |
Volume: |
7 |
Issue: |
19 |
Pages: |
26926-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schuldiner O |
Year: |
1996 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. |
Volume: |
93 |
Issue: |
14 |
Pages: |
7143-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Boyd KE |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
c-Myc target gene specificity is determined by a post-DNAbinding mechanism. |
Volume: |
95 |
Issue: |
23 |
Pages: |
13887-92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chung EY |
Year: |
2012 |
Journal: |
J Clin Invest |
Title: |
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. |
Volume: |
122 |
Issue: |
6 |
Pages: |
2257-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Freie B |
Year: |
2024 |
Journal: |
Genes Dev |
Title: |
A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies. |
Volume: |
38 |
Issue: |
5-6 |
Pages: |
253-272 |
|
•
•
•
•
•
|
Publication |
First Author: |
Link JM |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis. |
Volume: |
109 |
Issue: |
48 |
Pages: |
19685-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kovalchuk AL |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. |
Volume: |
109 |
Issue: |
27 |
Pages: |
10972-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Riu E |
Year: |
2002 |
Journal: |
Biochem J |
Title: |
Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism. |
Volume: |
368 |
Issue: |
Pt 3 |
Pages: |
931-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chappell J |
Year: |
2013 |
Journal: |
Genes Dev |
Title: |
MYC/MAX control ERK signaling and pluripotency by regulation of dual-specificity phosphatases 2 and 7. |
Volume: |
27 |
Issue: |
7 |
Pages: |
725-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pérez-Olivares M |
Year: |
2018 |
Journal: |
EMBO Rep |
Title: |
Functional interplay between c-Myc and Max in B lymphocyte differentiation. |
Volume: |
19 |
Issue: |
10 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Valente LJ |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. |
Volume: |
35 |
Issue: |
29 |
Pages: |
3866-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Santoni-Rugiu E |
Year: |
1996 |
Journal: |
Am J Pathol |
Title: |
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. |
Volume: |
149 |
Issue: |
2 |
Pages: |
407-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Varano G |
Year: |
2017 |
Journal: |
Nature |
Title: |
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition. |
Volume: |
546 |
Issue: |
7657 |
Pages: |
302-306 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin CH |
Year: |
2009 |
Journal: |
PLoS One |
Title: |
Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. |
Volume: |
4 |
Issue: |
11 |
Pages: |
e7839 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kundel DW |
Year: |
2012 |
Journal: |
Transgenic Res |
Title: |
Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc. |
Volume: |
21 |
Issue: |
2 |
Pages: |
393-406 |
|
•
•
•
•
•
|
Publication |
First Author: |
Petrashen AP |
Year: |
2023 |
Journal: |
Front Cell Dev Biol |
Title: |
Regulation of the somatotropic axis by MYC-mediated miRNA repression. |
Volume: |
11 |
|
Pages: |
1269860 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cottle DL |
Year: |
2013 |
Journal: |
Cell Rep |
Title: |
c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis. |
Volume: |
3 |
Issue: |
2 |
Pages: |
427-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim MJ |
Year: |
2018 |
Journal: |
Dev Cell |
Title: |
PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis. |
Volume: |
44 |
Issue: |
5 |
Pages: |
582-596.e4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hidalgo San Jose L |
Year: |
2020 |
Journal: |
Cell Rep |
Title: |
Modest Declines in Proteome Quality Impair Hematopoietic Stem Cell Self-Renewal. |
Volume: |
30 |
Issue: |
1 |
Pages: |
69-80.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mudhasani R |
Year: |
2008 |
Journal: |
J Cell Biol |
Title: |
Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. |
Volume: |
181 |
Issue: |
7 |
Pages: |
1055-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luong-Gardiol N |
Year: |
2019 |
Journal: |
Cancer Cell |
Title: |
γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia. |
Volume: |
35 |
Issue: |
4 |
Pages: |
649-663.e10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kopecky B |
Year: |
2011 |
Journal: |
Dev Dyn |
Title: |
Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear. |
Volume: |
240 |
Issue: |
6 |
Pages: |
1373-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mazur PK |
Year: |
2015 |
Journal: |
Nat Med |
Title: |
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. |
Volume: |
21 |
Issue: |
10 |
Pages: |
1163-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mazur PK |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. |
Volume: |
107 |
Issue: |
30 |
Pages: |
13438-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Karmaus PWF |
Year: |
2017 |
Journal: |
J Exp Med |
Title: |
Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis. |
Volume: |
214 |
Issue: |
9 |
Pages: |
2629-2647 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nahar R |
Year: |
2011 |
Journal: |
Blood |
Title: |
Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. |
Volume: |
118 |
Issue: |
15 |
Pages: |
4174-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pitt LA |
Year: |
2015 |
Journal: |
Cancer Cell |
Title: |
CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance. |
Volume: |
27 |
Issue: |
6 |
Pages: |
755-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
DÃaz-DÃaz C |
Year: |
2017 |
Journal: |
Dev Cell |
Title: |
Pluripotency Surveillance by Myc-Driven Competitive Elimination of Differentiating Cells. |
Volume: |
42 |
Issue: |
6 |
Pages: |
585-599.e4 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
32
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Jenkins NC |
Year: |
2016 |
Journal: |
J Neurooncol |
Title: |
Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice. |
Volume: |
126 |
Issue: |
3 |
Pages: |
415-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thompson TC |
Year: |
1995 |
Journal: |
Oncogene |
Title: |
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. |
Volume: |
10 |
Issue: |
5 |
Pages: |
869-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beer S |
Year: |
2004 |
Journal: |
PLoS Biol |
Title: |
Developmental context determines latency of MYC-induced tumorigenesis. |
Volume: |
2 |
Issue: |
11 |
Pages: |
e332 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stanton BR |
Year: |
1992 |
Journal: |
Genes Dev |
Title: |
Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. |
Volume: |
6 |
Issue: |
12A |
Pages: |
2235-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bae S |
Year: |
2017 |
Journal: |
J Clin Invest |
Title: |
MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα. |
Volume: |
127 |
Issue: |
7 |
Pages: |
2555-2568 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brindle NR |
Year: |
2015 |
Journal: |
PLoS One |
Title: |
Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer. |
Volume: |
10 |
Issue: |
4 |
Pages: |
e0120348 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maclean KH |
Year: |
2003 |
Journal: |
Mol Cell Biol |
Title: |
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. |
Volume: |
23 |
Issue: |
20 |
Pages: |
7256-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang J |
Year: |
2011 |
Journal: |
Leukemia |
Title: |
Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice. |
Volume: |
25 |
Issue: |
12 |
Pages: |
1857-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
He J |
Year: |
2019 |
Journal: |
Cancer Lett |
Title: |
Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma. |
Volume: |
458 |
|
Pages: |
113-122 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu L |
Year: |
2016 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent. |
Volume: |
113 |
Issue: |
6 |
Pages: |
1564-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shchors K |
Year: |
2006 |
Journal: |
Genes Dev |
Title: |
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. |
Volume: |
20 |
Issue: |
18 |
Pages: |
2527-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saddic LA |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma. |
Volume: |
6 |
Issue: |
5 |
Pages: |
e19758 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sandgren EP |
Year: |
1989 |
Journal: |
Oncogene |
Title: |
Oncogene-induced liver neoplasia in transgenic mice. |
Volume: |
4 |
Issue: |
6 |
Pages: |
715-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Möröy T |
Year: |
1990 |
Journal: |
EMBO J |
Title: |
IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis. |
Volume: |
9 |
Issue: |
11 |
Pages: |
3659-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Axelson H |
Year: |
1994 |
Journal: |
Genes Chromosomes Cancer |
Title: |
Juxtaposition of N-myc and Ig kappa through a reciprocal t(6;12) translocation in a mouse plasmacytoma. |
Volume: |
11 |
Issue: |
2 |
Pages: |
85-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mamada H |
Year: |
2015 |
Journal: |
J Cell Sci |
Title: |
Cell competition in mouse NIH3T3 embryonic fibroblasts is controlled by the activity of Tead family proteins and Myc. |
Volume: |
128 |
Issue: |
4 |
Pages: |
790-803 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rinaldi L |
Year: |
2017 |
Journal: |
Cell Death Dis |
Title: |
Mitochondrial AKAP1 supports mTOR pathway and tumor growth. |
Volume: |
8 |
Issue: |
6 |
Pages: |
e2842 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anbalagan M |
Year: |
2012 |
Journal: |
Int J Cancer |
Title: |
JNK1 and JNK2 play redundant functions in Myc-induced B cell lymphoma formation. |
Volume: |
130 |
Issue: |
8 |
Pages: |
1967-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yaron A |
Year: |
2005 |
Journal: |
Neuron |
Title: |
Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins. |
Volume: |
45 |
Issue: |
4 |
Pages: |
513-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sandgren EP |
Year: |
1995 |
Journal: |
Cancer Res |
Title: |
Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. |
Volume: |
55 |
Issue: |
17 |
Pages: |
3915-27 |
|
•
•
•
•
•
|